Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 2109B TAMOXIFENtamoxifen 10 mg tablet, 60 1 60 5
MPNP 2110C TAMOXIFENtamoxifen 20 mg tablet, 60 1 60 5
MPNP 10911G TAMOXIFENtamoxifen 20 mg tablet, 30 1 30 5
MPNP 1880Y TAMOXIFENtamoxifen 20 mg tablet, 30 2 60 5
MPNP 10096J TAPENTADOLtapentadol 50 mg modified release tablet, 28 1 28 0
MPNP 10091D TAPENTADOLtapentadol 200 mg modified release tablet, 28 1 28 0
MPNP 10100N TAPENTADOLtapentadol 150 mg modified release tablet, 28 1 28 0
MPNP 10094G TAPENTADOLtapentadol 100 mg modified release tablet, 28 1 28 0
MPNP 10092E TAPENTADOLtapentadol 250 mg modified release tablet, 28 1 28 0
MPNP 8356T TELMISARTANtelmisartan 80 mg tablet, 28 1 28 5
MPNP 8355R TELMISARTANtelmisartan 40 mg tablet, 28 1 28 5
MPNP 8979N TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 10 mg tablet, 28 1 28 5
MPNP 8980P TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 5 mg tablet, 28 1 28 5
MPNP 8981Q TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 10 mg tablet, 28 1 28 5
MPNP 8978M TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 5 mg tablet, 28 1 28 5
MPNP 8622T TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 8623W TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 9381R TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 25 mg tablet, 28 1 28 5
MPNP 2089Y TEMAZEPAMtemazepam 10 mg tablet, 25 1 25 0
MPNP 2088X TEMAZEPAMtemazepam 10 mg tablet, 25 2 50 5
MPNP 5375X TEMAZEPAMtemazepam 10 mg tablet, 25 2 50 3
MPNP 8527T TENECTEPLASEtenecteplase 10 000 units (50 mg) injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack 1 1 0
MPNP 8526R TENECTEPLASEtenecteplase 8000 units (40 mg) injection [1 vial] (&) inert substance diluent [8 mL syringe], 1 pack 1 1 0
MPNP 11276L TENOFOVIR + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 1 30 2
MPNP 11296M TENOFOVIR + EMTRICITABINEtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 1 30 2
MPNP 11306C TENOFOVIR + EMTRICITABINEtenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 1 30 2
MPNP 2285G TERBINAFINEterbinafine 250 mg tablet, 42 1 42 0
MPNP 2804N TERBINAFINEterbinafine 250 mg tablet, 42 1 42 1
MPNP 9160D TERBINAFINEterbinafine hydrochloride 1% cream, 15 g 2 2 3
MPNP 2817G TERBUTALINEterbutaline sulfate 500 microgram/actuation powder for inhalation, 100 actuations 2 2 5
MPNP 1034K TERBUTALINEterbutaline sulfate 500 microgram/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1330B TETRABENAZINEtetrabenazine 25 mg tablet, 112 1 112 5
MPNP 8231F THEOPHYLLINEtheophylline 300 mg modified release tablet, 100 1 100 5
MPNP 8230E THEOPHYLLINEtheophylline 200 mg modified release tablet, 100 1 100 5
MPNP 2634P THEOPHYLLINEtheophylline 250 mg modified release tablet, 100 1 100 5
MPNP 2614N THEOPHYLLINEtheophylline 133.3 mg/25 mL oral liquid, 500 mL 1 1 5
MPNP 1070H THIAMINEthiamine hydrochloride 100 mg tablet, 100 1 100 2
MPNP 8223T TIAGABINEtiagabine 15 mg tablet, 50 2 100 5
MPNP 8221Q TIAGABINEtiagabine 5 mg tablet, 50 2 100 5
MPNP 8222R TIAGABINEtiagabine 10 mg tablet, 50 2 100 5
MPNP 1418P TICAGRELORticagrelor 90 mg tablet, 56 1 56 5
MPNP 1465D TINIDAZOLEtinidazole 500 mg tablet, 4 1 4 0
MPNP 10509D TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations 1 1 5
MPNP 11043F TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations 1 1 5
MPNP 8626B TIOTROPIUMtiotropium 18 microgram powder for inhalation, 30 capsules 1 30 5
MPNP 10557P TIOTROPIUM + OLODATEROLtiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 60 actuations 1 1 5
MPNP 8350L TIROFIBANtirofiban 12.5 mg/50 mL injection, 50 mL vial 1 1 2
MPNP 8872Y TOBRAMYCINtobramycin Injection 80 mg (base) in 2 mL (without preservative), 5 2 10 1
MPNP 1356J TOBRAMYCINtobramycin 80 mg/2 mL injection, 5 x 2 mL vials 2 10 1
MPNP 9480Y TOBRAMYCINtobramycin 500 mg/5 mL injection, 10 x 5 mL vials 1 10 1
MPNP 8372P TOPIRAMATEtopiramate 25 mg capsule, 60 1 60 5
MPNP 8163P TOPIRAMATEtopiramate 25 mg tablet, 60 1 60 5
MPNP 8371N TOPIRAMATEtopiramate 15 mg capsule, 60 1 60 5
MPNP 8164Q TOPIRAMATEtopiramate 50 mg tablet, 60 1 60 5
MPNP 8165R TOPIRAMATEtopiramate 100 mg tablet, 60 1 60 5
MPNP 8520K TOPIRAMATEtopiramate 50 mg capsule, 60 1 60 5
MPNP 8166T TOPIRAMATEtopiramate 200 mg tablet, 60 1 60 5
MPNP 8843K TRAMADOLtramadol hydrochloride 100 mg/mL oral liquid, 10 mL 1 1 0
MPNP 8524P TRAMADOLtramadol hydrochloride 150 mg modified release tablet, 20 1 20 0
MPNP 8523N TRAMADOLtramadol hydrochloride 100 mg modified release tablet, 20 1 20 0
MPNP 8455B TRAMADOLtramadol hydrochloride 50 mg capsule, 20 1 20 0
MPNP 8611F TRAMADOLtramadol hydrochloride 50 mg capsule, 20 1 20 2
MPNP 2527B TRAMADOLtramadol hydrochloride 50 mg modified release tablet, 20 1 20 0
MPNP 8525Q TRAMADOLtramadol hydrochloride 200 mg modified release tablet, 20 1 20 0
MPNP 3484J TRAMADOLtramadol hydrochloride 100 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 8582Q TRAMADOLtramadol hydrochloride 100 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 8758Y TRANDOLAPRILtrandolapril 4 mg capsule, 28 1 28 5
MPNP 2792Y TRANDOLAPRILtrandolapril 1 mg capsule, 28 1 28 5
MPNP 2793B TRANDOLAPRILtrandolapril 2 mg capsule, 28 1 28 5
MPNP 2791X TRANDOLAPRILtrandolapril 500 microgram capsule, 28 1 28 5
MPNP 2857J TRANDOLAPRIL + VERAPAMILtrandolapril 4 mg + verapamil hydrochloride 240 mg modified release tablet, 28 1 28 5
MPNP 9387C TRANDOLAPRIL + VERAPAMILtrandolapril 2 mg + verapamil hydrochloride 180 mg modified release tablet, 28 1 28 5
MPNP 2180R TRANEXAMIC ACIDtranexamic acid 500 mg tablet, 100 1 100 2
MPNP 2990J TRIAMCINOLONEtriamcinolone acetonide 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 2118L TRIAMCINOLONEtriamcinolone acetonide 0.02% ointment, 100 g 2 2 0
MPNP 2117K TRIAMCINOLONEtriamcinolone acetonide 0.02% cream, 100 g 2 2 0
MPNP 2971J TRIAMCINOLONE + NEOMYCIN SULFATE + GRAMICIDIN + NYSTATINtriamcinolone acetonide 0.1% + neomycin sulfate 0.25% + gramicidin 0.025% + nystatin 100 000 international units/mL ear drops, 7.5 mL 1 1 2
MPNP 2974M TRIAMCINOLONE + NEOMYCIN SULFATE + GRAMICIDIN + NYSTATINtriamcinolone acetonide 0.1% + neomycin sulfate 0.25% + gramicidin 0.025% + nystatin 100 000 international units/g ointment, 5 g 1 1 2
MPNP 9309Y TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 6 x 1 L bottles 4 4 5
MPNP 10189G TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 27 x 200 mL cartons 2 2 5
MPNP 9308X TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cans 6 6 5
MPNP 3136C TRIGLYCERIDES MEDIUM CHAIN AND LONG CHAIN WITH GLUCOSE POLYMERtriglycerides medium chain and long chain with glucose polymer powder for oral liquid, 400 g 8 8 5
MPNP 10152H TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g 8 8 5
MPNP 10154K TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g 8 8 5
MPNP 10155L TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g 8 8 5
MPNP 1938B TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g 8 8 5
MPNP 8478F TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g 8 8 5
MPNP 9383W TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 30 x 16 g sachets 4 4 5
MPNP 10375C TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula oral liquid, 8 x 500 mL pouches 8 8 5
MPNP 1110K TRIHEXYPHENIDYL (BENZHEXOL)trihexyphenidyl (benzhexol) hydrochloride 5 mg tablet, 200 1 200 1
MPNP 1109J TRIHEXYPHENIDYL (BENZHEXOL)trihexyphenidyl (benzhexol) hydrochloride 2 mg tablet, 200 1 200 2
MPNP 2922T TRIMETHOPRIMtrimethoprim 300 mg tablet, 7 1 7 1
MPNP 2951H TRIMETHOPRIM + SULFAMETHOXAZOLEtrimethoprim 160 mg + sulfamethoxazole 800 mg tablet, 10 1 10 1
MPNP 3103H TRIMETHOPRIM + SULFAMETHOXAZOLEtrimethoprim 40 mg/5 mL + sulfamethoxazole 200 mg/5 mL oral liquid, 100 mL 1 1 1
MPNP 2746M TROPISETRONtropisetron 5 mg/5 mL injection, 5 mL ampoule 1 1 0
MPNP 9165J TYROSINE WITH CARBOHYDRATEtyrosine with carbohydrate containing 1 g tyrosine oral liquid: powder for, 30 x 4 g sachets 4 4 5